PDS Biotechnology Corp - Common Stock, par value $0.00033 per share (PDSB)

CUSIP: 70465T107

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 6 signals
Share change
-2,833,364
SEC-reported price per share
$0.60
Number of holders
40
Value change
-$1,761,034
Number of buys
14
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
102,192,638

Security key

70465T107

Report period

Q1 2026

Institutions

40

Top holders

10

Ownership snapshot

Top reported holders of PDSB - PDS Biotechnology Corp - Common Stock, par value $0.00033 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
DeLyle W. Bloomquist
Disclosed value leader
DeLyle W. Bloomquist
Comparable rows
0/15
Latest evidence
12 Jan 2026
3/4/5 13F Highest disclosed value: $7,813,350 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

DeLyle W. Bloomquist has the largest disclosed position value at $7.81M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens DeLyle W. Bloomquist's linked filing trail.
Disclosed position value Top 5
DeLyle W. Bloomquist $7.81M
ARMISTICE CAPITAL, LLC $2.18M
VANGUARD GROUP INC $1.5M
BlackRock, Inc. $402K
GEODE CAPITAL MANAGEMENT, LLC $400.7K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
DeLyle W. Bloomquist
3/4/5
Resigned as a Director on June 17, 2021.
—
mixed-class rows
$7,813,350
804,941 shares
mixed-class rows
— 16 Jun 2021
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$2,182,003
2,834,506 shares
— 31 Dec 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,502,228
1,950,946 shares
— 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$401,998
522,211 shares
— 31 Dec 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$400,666
520,398 shares
— 31 Dec 2025
UBS Group AG
13F
Company
13F
—
denominator unverified
$193,812
251,705 shares
— 31 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
40
Shares
5,047,213
Rows available
40
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
40
Q1 2026 holders
40
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .